Related Experiment Video
Updated: Jun 1, 2026

Estimating Bilateral Atrial Function by Cardiovascular Magnetic Resonance Feature Tracking in Patients with Paroxysmal Atrial Fibrillation
Published on: July 20, 2022
Clinical implications of left atrial enlargement: a review
Insights
Left atrial size, measured by echocardiography, predicts cardiovascular outcomes. Routine assessment of left atrial size may identify preclinical cardiovascular disease risk.
Area of Science:
- Cardiology
- Medical Imaging
Background:
- Left atrial (LA) size is a significant predictor of cardiovascular (CV) outcomes.
- LA enlargement has established pathophysiologic determinants and clinical implications.
Purpose of the Study:
- To review the physiology and echocardiographic assessment of LA size and functions.
- To describe the pathophysiologic determinants and clinical implications of LA enlargement.
Main Methods:
- Review of existing literature on echocardiographic assessment of LA size.
- Analysis of pathophysiologic factors contributing to LA enlargement.
- Evaluation of clinical implications of LA size in cardiovascular disease.
Main Results:
- Echocardiographically determined LA size is a significant predictor of CV outcomes.
- Standardized LA size assessment and its clinical applicability require further determination.
- LA size may serve as a crucial risk identifier in preclinical CV disease.
Conclusions:
- Echocardiographically determined LA size is a valuable metric for predicting CV outcomes.
- Routine echocardiographic evaluation should include LA size assessment.
- Further standardization is needed for widespread clinical application.
Abstract:
Echocardiographically determined left atrial (LA) size has been shown to be a significant predictor of cardiovascular (CV) outcomes. We review the physiology and echocardiographic assessment of LA size and functions and describe the pathophysiologic determinants and clinical implications of LA enlargement. However, despite strong evidence, standardized LA size assessment and generalized applicability of its clinical implications to patient care have yet to be determined. Nevertheless, current findings suggest that echocardiographically determined LA size may become an important clinical risk identifier in preclinical CV disease and should be assessed as a part of routine comprehensive echocardiographic evaluation.
Related Concept Videos
Mitral Regurgitation I: Introduction
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Cardiac Catheterization III: Left Heart Catheterization
Mitral Stenosis II: Clinical features and Diagnostic Tests
Aortic Regurgitation I: Introduction
